Citigroup Maintains Buy on Sana Biotechnology, Lowers Price Target to $11
Citigroup analyst Samantha Semenkow maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price target from $12 to $11.
Last updated: 2026-11-19 18:05:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Sana Biotechnology, Inc. (SANA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.78, with a market capitalization of $563.31M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.76 to $5.49. This page covers its latest market performance, valuation, price trends and company information.
$563.31M | |
$1.86 | |
$1.89 | |
$1.76 | |
$1.85 | |
1.79M | |
3.27M | |
-- | |
$5.49 | |
$1.76 | |
-- | |
2026-09-30 |
Sana Biotechnology, Inc. (SANA) is currently trading at $1.78 as of 2026-11-19 17:48:18, down 3.51% ($0.07) from the previous close of $1.85
During today's regular trading session, SANA has traded between $1.76 and $1.89, with a trading volume of 1.79M shares. The current price is near the lower end of today's range.
Over the past seven days, Sana Biotechnology, Inc. (SANA) moved from $2.43 to $1.78, representing a decline of 26.95% ($0.66).
The stock traded between $1.76 and $2.52 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.11 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.5%
SANA is currently trading at $1.78, placing it 0.5% of the way from its 52-week low of $1.76 to its 52-week high of $5.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 142 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Sana Biotechnology, Inc. and SANA stock.
Citigroup analyst Samantha Semenkow maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price target from $12 to $11.
Morgan Stanley analyst Maxwell Skor maintains Sana Biotechnology (NASDAQ:SANA) with a Overweight and raises the price target from $12 to $13.
Eligible investors can buy real shares of Sana Biotechnology, Inc. (SANA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SANA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SANA shares and USD.
SANA Shares to USD
1.00 SANA shares = 1.775 USD
Calculations are estimates based on the latest available price and are for reference only.